D-0517-2024 Class II Ongoing
FDA drug recall D-0517-2024 was initiated by Rubicon Research Private Limited on May 6, 2024 and is designated Class II. Reason for recall: Presence of Foreign Substance: metal in tablet The recall status is ongoing. Affected quantity: 11,664 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 5, 2024
- Initiation Date
- May 6, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,664 Bottles
Product description
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00
Reason for recall
Presence of Foreign Substance: metal in tablet
Distribution pattern
Nationwide
Code information
Lot 231037H1, exp 6/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0517-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026